David T. Domzalski
Net Worth
Last updated:
What is David T. Domzalski net worth?
The estimated net worth of Mr. David T. Domzalski is at least $4,986,950 as of 8 Sep 2020. He owns shares worth $448,350 as insider and has received compensation worth at least $4,538,600 in VYNE Therapeutics Inc..
What is the salary of David T. Domzalski?
Mr. David T. Domzalski salary is $907,720 per year as Chief Executive Officer, Pres & Director in VYNE Therapeutics Inc..
How old is David T. Domzalski?
Mr. David T. Domzalski is 58 years old, born in 1967.
What stocks does David T. Domzalski currently own?
As insider, Mr. David T. Domzalski owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
VYNE Therapeutics Inc. (VYNE) | Chief Executive Officer, Pres & Director | 1,315,966 | $0.34 | $448,350 |
What does VYNE Therapeutics Inc. do?
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.
David T. Domzalski insider trading
VYNE Therapeutics key executives
VYNE Therapeutics Inc. executives and other stock owners filed with the SEC:
- Mr. David T. Domzalski (58) Chief Executive Officer, Pres & Director
- Ms. Mutya Harsch J.D. (50) Gen. Counsel, Chief Legal Officer & Company Sec.